TrumpRx Expands Discount Drug Access With 600 Generic Medications 
Alphabet Raises Record $3.6 Billion in Yen Bonds to Support AI Expansion 
Anthropic to Brief Financial Stability Board on AI-Driven Cyber Risks 
Berkshire Hathaway Reveals New Stakes in Delta Air Lines and Macy’s Under Greg Abel 
Samsung, Union Edge Closer to Deal as Strike Threat Looms 
US-China Trade Talks Sideline Chip Export Controls as Nvidia China Sales Draw Attention 
Elliott Targets Bio-Rad as Shares Continue to Struggle 
YouTube and Snap Settle School District Mental Health Lawsuit Ahead of Major Social Media Trial 
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness 
Japan Airlines Signs 10-Year Boeing 787 Maintenance Deal With GE Aerospace 
Samsung Union Talks Enter Final Stage as Strike Threat Looms 
FTC Antitrust Probe Targets Arm Holdings Over Chip Licensing Practices 
Standard Chartered Appoints Manus Costello as New CFO Amid Leadership Reshuffle 
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 
 - EconoTimes)
NEW YORK, Sept. 16, 2016 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Sizmek, Inc. (“Sizmek” or the “Company”) (Nasdaq: SZMK) in the United States District Court for the Western District of Texas on behalf of current stockholders of Sizmek, seeking to pursue remedies under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges that the Board of Directors of Sizmek breached their fiduciary duties by causing a materially incomplete and misleading Recommendation Statement (the “Recommendation Statement”), to be filed with the SEC. The Complaint further alleges that merger consideration Sizmek stockholders will receive in connection with the transaction does not reflect the fair value of Sizmek shares.
If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.
